September 21, 2020 by Todd Huseby, Rodey Wing and Emily Rowe
coronavirus (COVID-19), health care, health care costs, pharmacy benefit manager (PBM)
Pharmacy, September 21, 2020

Today’s retail pharmacies face increasing pressure from all fronts. Governments are aiming to reduce health care costs, and public sentiment is pushing the industry toward a value-based model. The use of high-cost specialty drugs is increasing dispensing complexity and shifting channel volume — at a time when disruptors like Amazon are poised to impact pricing.
August 10, 2020 by Chain Drug Review
CDC, coronavirus (COVID-19), Diamond Wipes, Handy Clean Steridol Wipes
Supplier News, Uncategorized

CHINO, Calif. — Diamond Wipes announced on Monday that its HandyClean Steridol Wipes has demonstrated effectiveness against viruses similar to 2019 novel coronavirus (COVID-19) on hard, non-porous surfaces, and can be used against 2019 novel coronavirus (COVID-19) when used in accordance with the directions for use against norovirus on hard, non-porous surfaces. Refer to the
April 29, 2020 by Chain Drug Review
coronavirus (COVID-19), COVID-19 testing, eTrueNorth, Health Mart
Leading Headlines, Pharmacy, Retail News

FORT WORTH, Texas — U.S.-based healthcare technology company eTrueNorth is enabling new drive-through COVID-19 testing sites that are opening daily in partnership with a growing list of national pharmacy chains that include Walmart, The Kroger Co., and McKesson’s Health Mart. Work to begin this public-private partnership began on March 13 and includes funding by the
March 29, 2020 by Chain Drug Review
Abbott, coronavirus (COVID-19), ID NOW COVID-19 tests, Robert Ford
Leading Headlines, Pharmacy, Supplier News

ABBOTT PARK, Ill. — Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the
March 24, 2020 by Chain Drug Review
CNS Pharmaceuticals, coronavirus (COVID-19), Mariusz Olejniczak, WP1122, WPD Pharmaceuticals
Leading Headlines, Pharmacy, Supplier News

VANCOUVER, British Columbia — WPD Pharmaceuticals announced it has entered into a development agreement with CNS Pharmaceuticals for the development of several preclinical drug candidates including WP1122, which will be tested on a range of viruses including the coronavirus SARS-CoV-2. WPD has licensed rights to a portfolio of drug candidates, including WP1122, through its license partner,
March 18, 2020 by Chain Drug Review
coronavirus (COVID-19), Richard Ashworth, Walgreens
Leading Headlines, Retail News

DEERFIELD, Ill. — To better support its store team members during the COVID-19 pandemic, while also continuing to meet the needs of customers and communities, Walgreens has adjusted its operating hours. Beginning tomorrow, Thursday, March 19, most Walgreens stores nationwide will have adjusted operating hours. Most Walgreens locations, including 24-hour stores, will now be open
March 18, 2020 by Chain Drug Review
coronavirus (COVID-19), Hy-Vee, Randy Edeker
Leading Headlines, Retail News

WEST DES MOINES, Iowa — Hy-Vee announced Wednesday that due to evolving concerns regarding coronavirus (COVID-19), it is adapting the ways in which it serves customers to ensure they receive the products they need while keeping customers, employees and communities healthy and safe. • Store Hours: Beginning Wednesday, March 18, Hy-Vee stores will close at
March 16, 2020 by Chain Drug Review
coronavirus (COVID-19), Kaiser Permanente Washington Health Research Institute (KPWHRI), NIAID director Dr. Anthony Fauci.
Leading Headlines, Pharmacy

SEATTLE — A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) here. The National Institute of Allergy and Infectious Diseases (NIAID) , <https://www.niaid.nih.gov/diseases-conditions/coronaviruses>, part of the National Institutes of Health, is funding the trial. KPWHRI is part
March 16, 2020 by Chain Drug Review
coronavirus (COVID-19), OptimizeRx, William Febbo
Leading Headlines, Pharmacy

ROCHESTER, Mich. — OptimizeRx has launched a free interactive text message alert program available to the general public that delivers coronavirus (COVID-19) information issued by the Centers for Disease Control and Prevention (CDC) directly to any SMS-enabled mobile device. The COVID-19 Public Alert System was developed by the OptimizeRx patient engagement team to help the